Research Article

Allelic Imbalance in TOR1A mRNA Expression in Manifesting and Non-Manifesting Carriers of the GAG-Deletion

Table 2

Expression ratio of WT to ΔGAG TOR1A in lymphoblasts from MC and NMC.

Lymphoblasts
RNA cDNA samples
Samples WT/ΔGAGPhenotypeDetected alleleMCp ± S.D
ΔCpCorrected ΔCpFold expression

1MCWT27.64 ± 0.220.560.702−0.70
ΔGAG27.18 ± 0.13
2MCWT24.71 ± 0.080.380.522−0.52
ΔGAG24.33 ± 0.16
3MCWT24.87 ± 0.080.210.352−0.35
ΔGAG24.66 ± 0.06
4MCWT25.87 ± 0.150.360.502−0.50
ΔGAG25.51 ± 0.25
5MCWT
27.93 ± 0.13 0.070.212−0.21
ΔGAG27.87 ± 0.29
6NMCWT26.58 ± 0.160.390.532−0.53
ΔGAG26.19 ± 0.04
7NMCWT24.8 ± 0.080.140.282−0.28
ΔGAG24.67 ± 0.41
8NMCWT29.79 ± 0.170.310.452−0.45
ΔGAG29.49 ± 0.33
9NMCWT28.53 ± 0.210.440.582−0.58
ΔGAG28.09 ± 0.35
10NMCWT26.93 ± 0.100.290.432−0.43
ΔGAG26.63 ± 0.19
Genomic DNA WT26.06 ± 0.14−0.14020
WT/ΔGAGΔGAG26.2 ± 0.48

WT/WT: homozygous for the normal allele; WT/ΔGAG-TOR1A: carrier heterozygous for the mutant allele; AS-F, ASWT-R, ASΔE-R: allelic-specific set of primers (Figure 1); MC: manifesting carrier; NMC: non-manifesting carrier; MCp ± S.D: mean Cp values of triplicates for each reaction; ΔCp: MCp for WT minus MCp for mutant allele primer for each sample; corrected ΔCp: mean ΔCp of each RNA sample minus ΔCp of heterozygous genomic DNA sample.